About 35 in every 100,000 people live with sarcoidosis in the U.S., and most are located near urban areas on the East Coast, a study reports.| Sarcoidosis News
Löfgren syndrome is an acute but usually milder form of sarcoidosis, characterized by patches of inflammatory cells called granulomas, that usually resolves with or without treatment.| Sarcoidosis News
Teresa Carvalho is a science writer for Sarcoidosis News with an MS in cell and molecular biology. She covers the latest news and information on a variety of sarcoidosis topics.| Sarcoidosis News
Treatment with rituximab can lead to meaningful improvements for some people with neurosarcoidosis affecting the brain and/or spinal cord — particularly those with hard-to-treat disease and involvement limited to some […] The post Rituximab treatment may help some neurosarcoidosis patients appeared first on Sarcoidosis News.| Sarcoidosis News – The Web's Daily Resource for Sarcoidosis News
Sitting at the infusion center for my intravenous immunoglobulin (IVIG) treatment, I opened up a Google Docs tab on my laptop. I’d just gotten an idea for a column, and […] The post With chronic illnesses like sarcoidosis, community is key appeared first on Sarcoidosis News.| Sarcoidosis News – The Web's Daily Resource for Sarcoidosis News
Sarcoidosis is a chronic, multi-organ disease for most patients, with the potential to become more severe over time, a study has found.| Sarcoidosis News
The Web's Daily Resource for Sarcoidosis News| Sarcoidosis News
EFZO-FIT, a Phase 3 clinical study testing efzofitimod for pulmonary sarcoidosis, failed to meet its main goal of significantly reducing the need for corticosteroids among people with the rare inflammatory disease. […] The post Efzofitimod misses main goal in large pulmonary sarcoidosis trial appeared first on Sarcoidosis News.| Sarcoidosis News – The Web's Daily Resource for Sarcoidosis News
People with sarcoidosis who respond poorly to tumor necrosis factor inhibitors (TNFi) — used to treat the immune system disease when other therapies haven’t worked — frequently develop anti-drug antibodies […] The post Monitoring for anti-drug antibodies may help improve sarcoidosis care appeared first on Sarcoidosis News.| Sarcoidosis News – The Web's Daily Resource for Sarcoidosis News
When combined, four newly found blood biomarkers nearly perfectly predicted disease progression in pulmonary sarcoidosis patients in a study.| Sarcoidosis News
Steve Bryson is a science writer for Sarcoidosis News with a PhD in biochemistry. He covers the latest news and information on a variety of sarcoidosis topics.| Sarcoidosis News
Black women with sarcoidosis have a nearly twofold higher risk of kidney stones, with the odds increasing with metabolic conditions.| Sarcoidosis News
Read about how wide-ranging sarcoidosis symptoms are, and how they often affect the lungs but also can affect many other organs.| Sarcoidosis News
Among people with cardiac sarcoidosis on immunosuppressants, heart involvement alone linked with more serious events in a small study.| Sarcoidosis News
Category archive page for News.| Sarcoidosis News
Cardiac sarcoidosis is systemic sarcoidosis that affects the heart muscle, and raises the risk of arrhythmias and congestive heart failure.| Sarcoidosis News
I started writing this column a few weeks ago when I was angry. I was irate, it was festering, and I had to get it out. I started jotting down […] The post It’s OK to get angry when our best-laid plans go awry appeared first on Sarcoidosis News.| Sarcoidosis News – The Web's Daily Resource for Sarcoidosis News
The test, which includes new echocardiography techniques and heart damage blood markers, was an improvement over the frequent HRS algorithm.| Sarcoidosis News
Tailored therapeutics for ocular sarcoidosis should start with glucocorticoids, followed by immunosuppressants and biologics, per a study.| Sarcoidosis News
Columnist Kerry Wong, defending her need for cheese, finds diet, exercise, and socializing choices should consider mental and emotional needs.| Sarcoidosis News
The risk of developing sarcoidosis in adulthood may be associated with microbial exposure in daily life during childhood, a study found.| Sarcoidosis News
The final participant has completed the last visit as part of EFZO-FIT, a Phase 3 clinical trial testing Atyr Pharma’s experimental treatment efzofitimod, in adults with pulmonary sarcoidosis. Top-line results are […] The post Final visit completed in Phase 3 EFZO-FIT clinical trial of efzofitimod appeared first on Sarcoidosis News.| Sarcoidosis News – The Web's Daily Resource for Sarcoidosis News
The Foundation for Sarcoidosis Research (FSR) has awarded $450,000 to three scientists to support research projects related to sarcoidosis diagnosis, treatment, and care. This funding comes through FSR’s Early Career […] The post FSR awards 3 early career grants to advance sarcoidosis research appeared first on Sarcoidosis News.| Sarcoidosis News – The Web's Daily Resource for Sarcoidosis News
“When did the pain start?” That’s a fairly straightforward question with an uncomplicated answer for most people: “I fell last Thursday and hurt my knee.” “I was helping a friend […] The post Boiling frog syndrome: Symptoms of sarcoidosis turn up the heat appeared first on Sarcoidosis News.| Sarcoidosis News – The Web's Daily Resource for Sarcoidosis News
Sinonasal sarcoidosis, when the disease affects the nasal cavity and the surrounding air-filled cavities called the sinuses, mainly affects women and manifests as nasal obstruction, according to a review study. […] The post Women more likely to develop sinonasal sarcoidosis: Review study appeared first on Sarcoidosis News.| Sarcoidosis News – The Web's Daily Resource for Sarcoidosis News
The Foundation for Sarcoidosis Research (FSR) has launched an enhanced version of its patient registry, FSR-SARC, to help maximize the impact of patient participation in research. “Now in its tenth year, […] The post FSR launches enhanced version of its sarcoidosis patient registry appeared first on Sarcoidosis News.| Sarcoidosis News – The Web's Daily Resource for Sarcoidosis News
Last week, my husband and I took a road trip to see the Yankees play the Reds in Cincinnati, checking another stadium off our bucket list. We went out for […] The post Finding joy while living with sarcoidosis is imperative appeared first on Sarcoidosis News.| Sarcoidosis News – The Web's Daily Resource for Sarcoidosis News
A new study from researchers in Turkey suggests that a ratio taking into account the amount of angiotensin-converting enzyme (ACE) and of lymphocytes, a type of white blood cell — […] The post Researchers ID potential biomarker in sarcoidosis for recurrent disease appeared first on Sarcoidosis News.| Sarcoidosis News – The Web's Daily Resource for Sarcoidosis News
Most people with inflammatory conditions reported overall satisfaction, convenience, and confidence when self-administering Acthar Gel (repository corticotropin injection) through a single-dose, prefilled injector called SelfJect. That’s according to a survey-based […] The post Acthar Gel SelfJect convenient, easy to use: Patient survey appeared first on Sarcoidosis News.| Sarcoidosis News – The Web's Daily Resource for Sarcoidosis News
This month, I watched the 78th annual Tony Awards, looking forward to performances from the year’s top shows. I’m always hoping to see my new favorites recognized and get ideas […] The post Symptoms of sarcoidosis keep us out of ‘the room where it happens’ appeared first on Sarcoidosis News.| Sarcoidosis News – The Web's Daily Resource for Sarcoidosis News
A Partner Grant from the Foundation for Sarcoidosis Research (FSR) and the American Thoracic Society (ATS) will support a research project focused on possible connections between air pollution and outcomes […] The post Grant funds research into air pollution’s effects on sarcoidosis appeared first on Sarcoidosis News.| Sarcoidosis News – The Web's Daily Resource for Sarcoidosis News
The first participants in a Phase 2 clinical trial testing brepocitinib, Roivant’s experimental oral treatment, in adults with cutaneous sarcoidosis have been dosed, and top-line results are expected in the second half […] The post Brepocitinib Phase 2 trial doses first cutaneous sarcoidosis patients appeared first on Sarcoidosis News.| Sarcoidosis News – The Web's Daily Resource for Sarcoidosis News
Methotrexate appears to take longer to start acting, but is no less effective than the corticosteroid prednisone as a first-line treatment for pulmonary sarcoidosis, according to the early findings of an […] The post Methotrexate slower, but effective in treating pulmonary sarcoidosis appeared first on Sarcoidosis News.| Sarcoidosis News – The Web's Daily Resource for Sarcoidosis News
Researchers analyzed data from the first of three HUNT Study surveys to have data on the prevalence, incidence, and mortality of sarcoidosis.| Sarcoidosis News
The safety and tolerability is being tested of two XTMAB-16 doses against a placebo in patients on a stable corticosteroid dose.| Sarcoidosis News
Sarcoidosis is marked by an over-reactive immune system that begins to attack healthy tissues, creating small clumps of inflammation called granulomas that interfere with and damage any of a number of organs.| Sarcoidosis News